ArticleJournal of nephrology2025
Acid-base implications of the Gibbs-Donnan effect during continuous veno-venous hemofiltration.
Article in Journal of nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis in-vitro and in-vivo study investigates the Gibbs-Donnan effect across the filter during continuous veno-venous hemofiltration (CVVH). In particular, we assessed its acid-base implications, applying the physical-chemical approach.
methodsA prospective, single-center study was conducted using the PrismaMax machine (Baxter). Two sets of in-vitro CVVH experiments (with and without albumin) were performed to quantify the Gibbs-Donnan effect. Electrolytes, glucose, and osmolarity changes were measured across the filter and in the ultrafiltrate. Strong ion difference and sieving coefficients of the main solutes were calculated. Similar measurements were performed in oligo-anuric critically ill patients undergoing CVVH.
resultsIn-vitro experiments without albumin showed a sieving coefficient of 1 for both positive and negative ions. On the contrary, when albumin was added, the sieving coefficient for sodium and chloride changed linearly with albumin concentration (r = -0.94, p < 0.001 for sodium, r = 0.88, p < 0.001 for chloride), resulting in a progressive linear increase in post-filter strong ion difference (β = 1.1, r = 0.77, p = 0.003). In 22 studied patients, calculated albumin concentration increased across the filter (2.2 ± 0.5 g/dL vs. 3.1 ± 0.7 g/dL), leading to sodium retention (138 ± 6 vs. 141 ± 6 mmol/L, p < 0.001) and chloride excretion (100 ± 5 vs. 97 ± 5 mmol/L, p < 0.001), thus resulting in a higher post-filter strong ion difference (46 ± 4 vs. 40 ± 4 mmol/L, p < 0.001).
conclusionsThese in-vitro and in-vivo studies demonstrate that albumin linearly affects the sieving coefficient of ions, increasing the strong ion difference of plasma water during its passage through the filter and thus having a systemic alkalizing effect.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.